Abstract
Wet dog shakes (WDS) are paroxysmal shudders of head, neck and trunk. This behavior has been observed when dipping animals into cold water (41), application of xylene to the für (39) and tactile stimulation around ears (1). Pharmacological studies revealed that WDS can be produced by administration of thyrotropin-releasing hormone (9,24,29,41,42), 5-Hydroxytryptamine (3,12), or kainic acid (5,25). WDS are also known as a classical sign of morphine abstinence in rats (40,43). In 1976, Bloom et al. first reported that this shaking behavior was elicited by acute administration of β-endorphln into the lateral ventricle in rats. Similar observations were made in rats with enkephalin (15). In addition, it was found that epileptic discharges were provoked by the intraventricular (icv) injection of opioid peptides and WDS always accompanied the onset of seizure discharges (15,16,37). These findings suggest that there may be an association between electrical seizure activities and WDS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Askew, H.R., Librecht, B.C., and Ratner, S.C., 1969, Effects of stimulus duration and repeated sessions on habituation on the head-shake response in the rat, J. Comp. Physiol. Psychol., 67:497–503.
Barbeau, A., and Huxtable, R.J., eds., 1978, “Taurine and Neurological Disorders”, Raven Press, New York.
Bedard, P., and Pycock, C.J., 1977, ‘Wet-dog’ shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity, Neuropharmacology, 16:663–670.
Bloom, F., Segal, D., Ling, N., and Giullemin, R., 1976, Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness, Science, 194:630–632.
Collins, R.C., McLean, M., and Olney, J., 1980, Cerebral metabolic response to systemic kainic acid: 14-C-deoxyglucose studies, Life Sci., 27:855–862.
Collu, R., Charpente, G., and Clermont, M.J., 1978, Antagonism by taurine of morphine induced growth hormone secretion, Canad. J. Neurol. Sci., 5:139–142.
Contreras, E., and Tamayo, L., 1984, Effects of taurine on tolerance to and dependence on morphine in mice, Arch. Int. Pharmacodyn., 267:224–231.
Corrigall, W.A., and Linseman, M.A., 1980, A specific effect of morphine on evoked activity in the rat hippocampal slice, Brain Res., 192:227–238.
Costall, B., Hui, S.C.G., Metcalf, G., and Naylor, R.J., 1979, A study of the changes in motor behavior caused by TRH on intracerebral injection, Eur. J. Pharmacol., 53:143–150.
Cowan, A., and Tortella, F.C., 1982, A quantitative analysis of the shaking behavior induced in rats by ß-endorphin and [D-Ala2, Met5] enkephalinamide, Life Sci., 30:171–176.
Dingledlne, R., 1981, Possible mechanisms of enkephalin action of hippocampal CA1 pyramidal neurons, J. Neurosci., 1:1022–1035.
Drust, E.G., Sloviter, R.S., and Connor, J.D., 1979, Effect of morphine on ‘wet-dog’ shakes caused by cerebroventricular injection of serotonin, Pharmacology, 18:299–305.
Dunwiddie, T., Mueller, A., Palmer, M., Stewart, J., and Hoffer, B., 1980, Electrophysiological interactions of enkephalins with neuronal circuitry in the rat hippocampus. I. effects on pyramidal cell activity, Brain Res., 184:311–330.
Durelli, L., and Mutani, R., 1983, The current status of taurine in epilepsy, Clin. Neuropharmacology, 6:37–48.
Frenk, H., Urca, G., and Liebenskind, J.C., 1978, Epileptic properties of leucine-and methlonine-enkephalin: comparison with morphine and reversibility by naloxone, Brain Res., 147:327–337.
Henriksen, S.J., Bloom, F.E., McCoy, F., Ling, N., and Guillemln, R., 1978, β-Endorphin induces nonconvulsive limbic seizures, Proc. Natl. Acad. Sci. USA, 75:5221–5225.
Huxtable, R.J., 1981, Insights on function: metabolism and pharmacology of taurine in the brain, in: “The Role of Peptldes and Amlno Acids as Neurotransmitters”, J.B. Lombardini, and A.D. Kenny, eds., Alan R. Liss, Inc., New York, pp.53–97.
Izumi, K., Donaldson, J. Minnich, J.L., and Barbeau, A., 1973, Ouabain-induced seizures in rats: suppressive effects of taurine and 7-aminobutyric acid, Canad. J. Physiol. Pharmacol., 51:885–889.
Izumi, K., Igisu, H., and Fukuda, T., 1974, Suppression of seizures by taurine — specific or non-specific?, Brain Res., 76:171–173.
Izumi, K., Kishita, C., Koja, T., Shimizu, T., Fukuda, T., and Huxtable, R.J., 1985, Effects of guanidinoethane sulfonate and taurine on electroshock seizures in mice, in: “Guanidines”, A. Mori, B.D. Cohen, and A. Lowenthal, eds., Plenum Publishing Corporation, New York, pp. 227–234.
Izumi, K., Munekata, E., Barbeau, A., Nakanshi, T., Yoshida, M., Yamamoto, H., and Fukuda, T., 1982, Effects of taurine on tolerance to [D-Ala2, Met5]enkphalinamide in rats, Eur. J. Pharmacol., 82:55–63.
Izumi, K., Munekata, E., Yamamoto, H., Nakanishi, T., and Barbeau, A., 1980, Effects of taurine and 7-aminobutyric acid on akinesia and analgesia induced by D-Ala2-Met-enkephalinamide in rats, Peptides, 1:139–146.
Izumi, K., Munekata, E., Yamamoto, H., Nakanishi, T., and Barbeau, A., 1980, Possible involvements of taurine and GABA in morphine-like peptide actions, Int. J. Neurol., 14:253–268.
Kalivas, P.W., and Horita, A., 1980, Thyrotropin-releasing hormone: neurogenesls of actions in the pentobarbital narcotized rat, J. Pharmacol. Exp. Ther., 212:203–210.
Lanthorn, T., and Isaacson, R.L., 1978, Studies of kainate-induced wet-dog shakes in the rat, Life Sci., 22:171–178.
Le Gal La Salle, G., and Cavalheiro, E.A., 1981, Stimulation of septal and amygldaloid nuclei: EEG and behavioral responses during early development of kindling with special reference to wet-dog shakes, Exp. Neurol., 74:717–727.
Lee, H.K., Dunwiddie, T., and Hoffer, B., 1980, Electrophysiological interactions of enkephalins with neuronal circuitry in the rat hippocampus. II. effects of interneuronal excitability, Brain Res., 184:331–342.
Leybin, L., Pinsky, C, LaBella, F.S., Havlicek, V., and Rezek, M., 1976, Intraventricular Met5-enkephalin causes unexpected lowering of pain threshold and narcotic withdrawal signs in rats, Nature (Lond.), 264:458–459.
Martin, B.R., Dewey, W.L., Chau-Pham, T., and Prange, Jr., A.J., 1977, Interactions of thyrotropin releasing hormone and morphine sulfate in rodents, Life Sei., 20:715–722.
Masukawa, L.M., and Prince, D.A., 1982, Enkephalin inhibition of inhibitory input to CA1 and CA3 pyramidal neurons in the hippocampus, Brain Res., 249:271–280.
Nicoll, R.A., Alger, B.E., and Jahr, C.E., 1980, Enkephalin blocks inhibitory pathways in the vertebrate CNS, Nature (Lond.), 287:22–25.
Oja, S.S., and Kontro, P., 1983, Taurine, in: “Handbook of Neurochemistry”, Vol. 3 (2nd Ed.), A. Lajtha, ed., Plenum Publishing Corporation, New York, pp.501–533.
Siggins, G.R., and Zieglgansberger, W., 1981, Morphine and opioid peptides reduce inhibitory synaptic protentials in hippocampal pyramidal cells in vitro without alteration of membrane potential, Proc. Natl. Acad. Sci. USA, 78:5235–5239.
Snead III, O.C., and Bearden, L.J., 1980, Anticonvulsants specific for peti mal antagonize epileptogenic effect of leucine enkephalin, Science, 210:1031–1033.
Squillace, K.M., Post, R.M., and Pert, A., 1980, Development of wet-dog shakes during amygdala kindling in the rat, Exp. Neurol., 70:487–497.
Tortella, F.C., Moreton, J.E., and Khazan, N., 1979, Electroencephalographic and behavioral tolerance to and cross-tolerance between D-Ala2-Methionine-Enkephalinamide and morphine in the rat, J. Pharmacol. Exp. Ther., 210:174–179.
Urca, G., Frenk, H., and Liebeskind, J.C., 1977, Morphine and enkephalin: analgesic and epileptic properties, Science, 197:83–86.
Van Gelder, N.M., 1972, Antagonism by taurine of cobalt-induced epilepsy in cat and mouse, Brain Res., 47:157–165.
Wei, E., 1975, Resemblance of morphine antinociception to the central depressant actions of norepinephrine, Life Sci., 17:17–18.
Wei, E., Loh, H.H., and Way, E.L., 1973, Quantitative aspects of precipitated abstinence In morphine-dependent rats, J. Pharmacol. Exp. Ther., 184:398–403.
Wei, E., Loh, H.H., and Way, E.L., 1973, Neuroanatomical correlates of wet shake behaviour in the rat, Life Sci., 12:489–496.
Wei, E., Sigel, S., Loh, H.H., and Way, E.L., 1975, Thyrotropin-releasing hormone and shaking behaviour in the rat, Nature (Lond.), 253:739–740.
Wikler, A., Green, P.D., Smith, H.D., and Pescor, F.T., 1960, Use of a benzimidazole derivative with potent morphine-like properties as a presumptive reinforcer in conditioning of drug seeking behavior in rats, Fed. Proc, 19:22.
Yamamoto, H., McCain, H.W., Izumi, K., Misawa, S., and Way, E.L., 1981, Effects of amino acids, especially taurine and γ-aminobutyric acid (GABA), on analgesia and calcium depletion induced by morphine in mice, Eur. J. Pharmacol., 71:177–184.
Zieglgansberger, W., French, E.D., Siggins, G.R., and Bloom, F.E., 1979, Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons, Science, 205:415–417.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer Science+Business Media New York
About this chapter
Cite this chapter
Izumi, K., Yoshida, M., Koja, T., Munekata, E., Nakanishi, T., Fukuda, T. (1987). Taurine Inhibits Wet-Dog Shakes and Hippocampal Seizures Induced by Opioid Peptides in Rats. In: Huxtable, R.J., Franconi, F., Giotti, A. (eds) The Biology of Taurine. Advances in Experimental Medicine and Biology, vol 217. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0405-8_24
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0405-8_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0407-2
Online ISBN: 978-1-4899-0405-8
eBook Packages: Springer Book Archive